Zepp Health Corporation (ZEPP)
NYSE: ZEPP · Real-Time Price · USD
4.840
-0.080 (-1.63%)
Sep 9, 2026, 10:26 AM EDT - Market open

Zepp Health Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-40.07-75.73-31.02-43.2421.69
Depreciation & Amortization
4.545.027.698.718.17
Loss (Gain) From Sale of Assets
0.02-0.060.05-0.28-0.05
Asset Writedown & Restructuring Costs
--1.14--
Loss (Gain) From Sale of Investments
2.128.12-0.01-6.14-2.08
Loss (Gain) on Equity Investments
2.074.21-1.11-2.68-6.46
Stock-Based Compensation
2.494.788.797.2713.08
Provision & Write-off of Bad Debts
7.51.59-0.10.13
Other Operating Activities
11.3720.029.21.4211.54
Change in Accounts Receivable
-8.33-5.0836.38-22.87-37.76
Change in Inventory
-22.095.5651.9127.92-13.09
Change in Accounts Payable
28.314.81-27.82-135.34-105.98
Change in Income Taxes
-0.19-0.480.59-0.01-3.95
Change in Other Net Operating Assets
-13.41-7.14-13.1948.0478.15
Operating Cash Flow
-25.69-24.3942.6-117.11-36.59
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.52-1.4-1.6-1.21-7.25
Sale of Property, Plant & Equipment
0.61.754.74-0.4
Divestitures
--0.430.065.34
Sale (Purchase) of Intangibles
-0.27-0.09-0.08-0.27-1.11
Investment in Securities
1.67-1.845.65-2.52-165.72
Other Investing Activities
---1.4-2.30.02
Investing Cash Flow
1.48-1.587.73-6.24-168.32

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
197.2678.73123.54170.77231.96
Total Debt Issued
197.2678.73123.54170.77231.96
Short-Term Debt Repaid
-170.12-75.27-162.45-108.11-150.08
Total Debt Repaid
-170.12-75.27-162.45-108.11-150.08
Net Debt Issued (Repaid)
27.143.46-38.9162.6681.88
Issuance of Common Stock
----0.86
Repurchase of Common Stock
-1.24-2.28-2.52-8.16-2.17
Common Dividends Paid
----6.31-
Other Financing Activities
-1.07-0.71-0.25-5.836.17
Financing Cash Flow
24.840.48-41.6842.3786.75

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.58-4.24-9.31-14.77-2.45
Net Cash Flow
2.2-29.73-0.65-95.76-120.61

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-26.21-25.841.01-118.32-43.84
Free Cash Flow Growth
-----
Free Cash Flow Margin
-10.12%-14.13%11.62%-19.28%-4.46%
Free Cash Flow Per Share
-1.65-1.592.70-7.69-2.65
Levered Free Cash Flow
-14.54-3.6897.05-62.66-45.22
Unlevered Free Cash Flow
-10.98-0.21101.27-57.38-40.81

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1.240.096.278.37.42
Cash Income Tax Paid
-0.57-0.060.24-0.5111.71
Change in Working Capital
-15.737.6647.88-82.26-82.62
SEC Filings: 10-K · 10-Q